Highlights

  • Wesfarmers holds a 50% interest in the Covalent Lithium venture.
  • The Kwinana refinery has produced lithium hydroxide during commissioning.
  • The 2026 strategy briefing identified FY27 ramp-up and customer qualification as priorities.
  • Nameplate lithium hydroxide output was targeted for the second half of calendar 2027.

Wesfarmers Limited (ASX:WES) operates retail, industrial and chemical businesses, including an interest in the Covalent Lithium venture. Covalent’s Kwinana refinery in Western Australia is intended to process spodumene from the Mt Holland operation into lithium hydroxide. The project has achieved initial product manufacture, but the verified 2026 company disclosures distinguish this from a completed ramp-up to commercial nameplate capacity. WES investors therefore need to separate first product, ongoing commissioning, customer qualification and the subsequent capacity target.

Production versus steady-state operation

Wesfarmers’ June 2026 strategy briefing confirmed that high-quality lithium hydroxide had been produced and that refinery ramp-up and customer qualification were continuing. The same briefing targeted nameplate lithium hydroxide output in the second half of calendar 2027. This timeline does not support an assertion that full commercial production had already been reached in October 2026. Wesfarmers also reported that commissioning encountered intermittent odour issues; engineering measures were being implemented to permit an unconstrained increase in throughput. A plant can produce material during commissioning while still working toward consistent volumes and customer specifications.

Mine and refinery milestones are different

Covalent Lithium’s mine-and-refinery configuration brings together the Mt Holland spodumene mine and concentrator with the Kwinana conversion facility. Wesfarmers’ 2026 strategy presentation stated that nameplate spodumene production had been achieved during FY26, a milestone relating to mine concentrate rather than refinery chemical output. Its WesCEF division includes Wesfarmers’ 50% share of the venture. The company expected that share of FY27 spodumene concentrate production to be about 190,000 tonnes, allocated between refinery feedstock and external sales. These are forward-looking estimates and are not evidence of realised lithium hydroxide sales. For WES, reporting needs to preserve that important distinction.

Commercial qualification and financial implications

Battery-grade lithium hydroxide requires consistency of chemical composition and customer acceptance. Management’s focus on qualification indicates that production volume alone is not the complete measure of commercial readiness. In its FY26 half-year report, Wesfarmers explained that refinery ramp-up costs would continue to be capitalised until commercial production was achieved. Investors should examine subsequent WES disclosures for a formal commercial-production determination, shipped product volumes, operating costs and divisional earnings. The lithium business may influence WesCEF performance, but group earnings also reflect Bunnings, Kmart, Officeworks and other established businesses. These segments should not be blended with provisional refinery projections.

Additional Operating Context

Wesfarmers' official strategy materials also outlined its planned distribution of spodumene concentrate between supplying the Kwinana plant and third-party customers. That allocation matters because material retained as refinery feedstock may support later chemical output rather than immediate concentrate sales. Customer qualification is another distinct stage: making a sample that meets an internal target is not the same as completing the qualification and dispatch processes required for regular deliveries. These distinctions can help explain differences between operational progress and earnings recognised by WES while the project transitions out of commissioning.

Key Insights

Kwinana has passed first-product manufacture, while official 2026 materials describe ongoing refinery ramp-up and customer qualification. The stated second-half 2027 nameplate target is not an achieved 2026 result. WES reporting should be read carefully for a confirmed commercial-production announcement and the difference between mine concentrate and refined lithium hydroxide.